Posted May. 29, 2013 at 7:28 a.m.

Premium Lock GSK buys Swiss vaccine developer for $324M

Published: 2013-05-29 07:28:01
Updated: 2013-05-29 07:28:01


"This is a fantastic opportunity for patients and our research organisation as it is expected to contribute to the development efforts for an exciting new generation of vaccines, building on the excellent science and expertise of both companies," president of GSK Vaccines says....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders